 |
Article Review/Hyperlink
|
SPORTIF III Investigators
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III)
Lancet (Nov) 362:1691-1698, 2003
The abstract of this paper is available from the Lancet. However, you must register at the Lancet site first as a non-subscriber (you can get there via the journals page of HDCN).
Once you have registered at the Lancet site, click here for the abstract.
| Related Folders: |
|
|
